Trial Profile
A pilot trial to investigate the administration of von Willebrand factor concentrate (Willfact®, LFB France) in adult patients during extracorporeal membrane oxygenation
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2017
Price :
$35
*
At a glance
- Drugs Von Willebrand factor (Primary) ; Sodium chloride
- Indications Von Willebrand disease
- Focus Therapeutic Use
- 10 Aug 2017 Status changed from recruiting to discontinued.
- 31 Mar 2017 New trial record